Veterinary Medicines

ZADAREP ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • Ascorbic acid
  • TOCOPHERYL ACETATE
  • Colecalciferol Ph.Eur.
  • Retinol palmitate
Download as PDF

Product identification

Medicine name:
ZADAREP ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Ascorbic acid
  • TOCOPHERYL ACETATE
  • Colecalciferol Ph.Eur.
  • Retinol palmitate
Target species:
  • Horse
  • Cattle
  • Pig
  • Chicken
  • Rabbit
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ascorbic acid
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • TOCOPHERYL ACETATE
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol Ph.Eur.
    5000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    50000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Not applicable
        no withdrawal period
    • Cattle
      • Not applicable
        no withdrawal period
    • Pig
      • Not applicable
        no withdrawal period
    • Chicken
      • Not applicable
        no withdrawal period
    • Rabbit
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11BA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • PROVET S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Provet S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 1618/21-01-1991/K-0042401
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."